Sherwin-Williams (SHW) Price Target Raised to $527.00 at Argus

Sherwin-Williams (NYSE:SHW) had its price target upped by stock analysts at Argus from $480.00 to $527.00 in a research note issued on Friday, BenzingaRatingsTable reports. The firm presently has a “buy” rating on the specialty chemicals company’s stock. Argus’ target price points to a potential upside of 15.40% from the company’s previous close.

A number of other analysts also recently weighed in on the stock. Wolfe Research downgraded shares of Sherwin-Williams from an “outperform” rating to a “peer perform” rating in a report on Thursday. UBS Group boosted their price objective on Sherwin-Williams from $448.00 to $460.00 and gave the stock a “neutral” rating in a research note on Wednesday. Robert W. Baird boosted their price objective on Sherwin-Williams from $480.00 to $525.00 and gave the stock an “outperform” rating in a research note on Wednesday. Deutsche Bank boosted their price objective on Sherwin-Williams from $460.00 to $490.00 and gave the stock a “buy” rating in a research note on Wednesday. Finally, Barclays boosted their target price on Sherwin-Williams from $440.00 to $470.00 and gave the company an “equal weight” rating in a research report on Wednesday. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and fourteen have given a buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $480.05.

SHW traded up $5.37 during trading hours on Friday, hitting $456.67. The company’s stock had a trading volume of 338,364 shares, compared to its average volume of 538,445. Sherwin-Williams has a 12 month low of $355.28 and a 12 month high of $479.64. The stock has a market capitalization of $42.32 billion, a PE ratio of 24.64, a P/E/G ratio of 1.90 and a beta of 1.26. The company has a debt-to-equity ratio of 2.51, a quick ratio of 0.59 and a current ratio of 0.96.

Sherwin-Williams (NYSE:SHW) last announced its quarterly earnings results on Tuesday, April 23rd. The specialty chemicals company reported $3.60 earnings per share for the quarter, missing the consensus estimate of $3.63 by ($0.03). Sherwin-Williams had a return on equity of 47.07% and a net margin of 6.27%. The business had revenue of $4.04 billion during the quarter, compared to the consensus estimate of $4.09 billion. During the same quarter in the prior year, the firm posted $3.57 EPS. The company’s revenue for the quarter was up 1.9% on a year-over-year basis. As a group, research analysts forecast that Sherwin-Williams will post 20.98 earnings per share for the current year.

In other Sherwin-Williams news, insider Joel D. Baxter sold 7,621 shares of the company’s stock in a transaction on Thursday, February 21st. The stock was sold at an average price of $439.15, for a total value of $3,346,762.15. Following the transaction, the insider now owns 10,308 shares of the company’s stock, valued at approximately $4,526,758.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Jane M. Cronin sold 1,344 shares of the company’s stock in a transaction on Wednesday, February 20th. The shares were sold at an average price of $441.24, for a total value of $593,026.56. Following the completion of the transaction, the senior vice president now directly owns 4,078 shares in the company, valued at approximately $1,799,376.72. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 11,839 shares of company stock worth $5,186,817. Insiders own 0.50% of the company’s stock.

A number of institutional investors have recently made changes to their positions in the business. Vanguard Group Inc grew its stake in Sherwin-Williams by 0.9% in the 3rd quarter. Vanguard Group Inc now owns 7,104,385 shares of the specialty chemicals company’s stock worth $3,233,988,000 after acquiring an additional 62,550 shares in the last quarter. BlackRock Inc. grew its stake in Sherwin-Williams by 0.8% in the fourth quarter. BlackRock Inc. now owns 5,429,226 shares of the specialty chemicals company’s stock worth $2,136,182,000 after purchasing an additional 42,112 shares in the last quarter. Fiera Capital Corp grew its stake in Sherwin-Williams by 1.6% in the fourth quarter. Fiera Capital Corp now owns 1,402,576 shares of the specialty chemicals company’s stock worth $551,858,000 after purchasing an additional 22,248 shares in the last quarter. Geode Capital Management LLC grew its stake in Sherwin-Williams by 7.3% in the fourth quarter. Geode Capital Management LLC now owns 938,381 shares of the specialty chemicals company’s stock worth $368,468,000 after purchasing an additional 64,106 shares in the last quarter. Finally, Bank of New York Mellon Corp grew its stake in Sherwin-Williams by 0.4% in the fourth quarter. Bank of New York Mellon Corp now owns 787,358 shares of the specialty chemicals company’s stock worth $309,795,000 after purchasing an additional 3,282 shares in the last quarter. 77.67% of the stock is currently owned by institutional investors.

Sherwin-Williams Company Profile

The Sherwin-Williams Company develops, manufactures, distributes, and sells paints, coatings, and related products to professional, industrial, commercial, and retail customers. It operates in three segments: The Americas Group, Consumer Brands Group, and Performance Coatings Group. The Americas Group segment offers architectural paints and coatings, and protective and marine products, as well as OEM product finishes and related products for architectural and industrial paint contractors and do-it-yourself homeowners.

Read More: The risks of owning bonds

Analyst Recommendations for Sherwin-Williams (NYSE:SHW)

Receive News & Ratings for Sherwin-Williams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sherwin-Williams and related companies with MarketBeat.com's FREE daily email newsletter.